End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?

Kidney International

Volumn 59, Issue 2, 2001, Pages 407-414

  Arici, M ^a   Walls, J ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Acute phase response; Dialysis; Fatty streak lesion; Fibrous plaque; Immune response; Inflammatory disease; Uremia; Vascular disease

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CHEMOKINE; COMPLEMENT; CUPROPHANE; CYTOKINE; FIBRINOGEN; GROWTH FACTOR; LIPOPROTEIN; POLYSULFONE; THROMBOPLASTIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIALYSIS MEMBRANE; HUMAN; IMMUNE RESPONSE; KIDNEY FAILURE; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UREMIA;

EID: 0035134192     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.059002407.x     Document Type: Article

References (63)

1. Accelerated atherosclerosis in prolonged maintenance hemodialysis
2. Atherosclerosis: An inflammatory disease
3. Cardiovascular disase in dialysis patients
4. Cardiovascular disease in uremic patients on hemodialysis
5. Clinial epidemiology of cardiovascular disease in chronic renal failure
6. Atherosclerosis and arteriosclerosis in chronic failure
7. Evaluating novel cardiovascular risk factors: Can we do better predict heart attacks?
8. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
9. C-reactive protein, inflammation, and coronary risk
10. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
11. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
12. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid a protein
13. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
14. The acute phase response and C-reactive protein
15. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
16. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
17. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
18. C-reactive protein: Binding to lipids and lipoproteins
19. Binding of CRP to degraded, nonoxidized LDL enhances complement activation
20. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
21. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: Relationship with age, sex, and hormone replacement treatment
22. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
23. Production of C-reactive protein and risk of coronary events in stable and unstable angina
24. Evaluation of C-reactive protein in "active" coronary artery disease
25. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
26. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
27. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
28. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992
29. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
30. C-reactive protein response and progression of atherosclerosis: Is atherosclerosis the byproduct of systemic infection?
31. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
32. The physiological structure of human C-reactive protein and its complex with phosphocholine
33. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
34. Long-term effects of pravastatin on plasma concentration of C-reactive protein
35. C-reactive protein in haemodialysis patients with dialysis arthropathy
36. Elevated serum levels of C-reactive protein in hemodialysis patients
37. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
38. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
39. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
40. Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients
41. C-reactive protein and atherosclerosis in dialysis patients
42. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure
43. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
44. Plasma C-reactive protein in hemodialysis patients: A cross sectional, longitudinal clinical survey
45. Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1β levels and different dialysis membranes
46. High lipoprotein(a) levels in chronie hemodialysis patients are closely related to the acute phase reaction
47. Increase of C-reactive protein serum values following haemodialysis
48. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
49. Inflammation, nutritional state and outcome in end stage renal disease
50. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
51. Cytokines: Agents provocateurs in hemodialysis?
52. Elevated circulating levels of interleukin-6 in patients with chronic renal failure
53. Serum interleukin-6 in long-term hemodialyzed patients
54. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
55. The effects of the dialysis membrane on cytokine release
56. Hemodialysis-associated induction of cytokines
57. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis
58. Determinants of albumin concentration in hemodialysis patients
59. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation
60. Acute-phase proteins and other systemic responses to inflammation
61. Malnutrition, cardiac disease, and mortality: An integrated point of view
62. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients
63. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study